Cannara Biotech Market Cap

Cannara Biotech has a market cap or net worth of $93.77 million as of April 29, 2025. Its market cap has increased by 47.60% in one year.

Market Cap

93.77M

Enterprise Value

121.73M

Revenue

62.29M

Ranking

n/a

PE Ratio

19.79

Stock Price

$1.01

Market Cap Chart

Since January 14, 2019, Cannara Biotech's market cap has decreased from 159.42M to 93.77M, a decrease of -41.18%. That is a compound annual growth rate of -8.10%.

Market Cap History

Date	Market Cap	% Change
Apr 25, 2025	92.37M	99.51%
Dec 31, 2024	46.30M	-18.17%
Dec 29, 2023	56.58M	-8.15%
Dec 30, 2022	61.59M	-34.13%
Dec 31, 2021	93.50M	101.84%
Dec 31, 2020	46.32M	-31.99%
Dec 31, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	1.63B
Nika Pharmaceuticals	1.02B
Veradigm	743.17M
Glass House Brands	483.81M
Elite Pharmaceuticals	443.14M
Northwest Biotherapeutics	402.45M
CytoDyn	288.39M
BioStem Technologies	244.71M

Market Cap Rankings